Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junaid Hassan

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Oncotarget|January 14, 2016
Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanomaKe Hu, Savalan Babapoor-Farrokhran, Murilo Rodrigues, et al.
Oncotarget|March 22, 2021
Correction: Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanomaKe Hu, Savalan Babapoor-Farrokhran, Murilo Rodrigues, et al.
Diabetes|July 26, 2013
VEGF secreted by hypoxic Müller cells induces MMP-2 expression and activity in endothelial cells to promote retinal neovascularization in proliferative diabetic retinopathyMurilo Rodrigues, Xiaoban Xin, Kathleen Jee, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2015
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathySavalan Babapoor-Farrokhran, Kathleen Jee, Brooks Puchner, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Oncotarget|January 14, 2016
Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanomaKe Hu, Savalan Babapoor-Farrokhran, Murilo Rodrigues, et al.
Oncotarget|March 22, 2021
Correction: Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanomaKe Hu, Savalan Babapoor-Farrokhran, Murilo Rodrigues, et al.
Diabetes|July 26, 2013
VEGF secreted by hypoxic Müller cells induces MMP-2 expression and activity in endothelial cells to promote retinal neovascularization in proliferative diabetic retinopathyMurilo Rodrigues, Xiaoban Xin, Kathleen Jee, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2015
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathySavalan Babapoor-Farrokhran, Kathleen Jee, Brooks Puchner, et al.
Pageof 4